# Maestro by Moon Surgical Canonical page: https://technooptimist.io/robotics/maestro Frontier: [Robotics](https://technooptimist.io/robotics.md) · Field: Keyhole surgery robots · Company: [Moon Surgical](https://technooptimist.io/companies/moon-surgical.md) Stage: Deploy (4 of 5: Research → Proto → Pilot → Deploy → Scaling) Updated: last update 2026-06-09, facts checked 2026-10-11 Goal: Give every keyhole operation a tireless, steady assistant at a fraction of the cost of a full surgical robot. Fewer hands needed at the table eases staff shortages, and the data it gathers is the base for automating parts of surgery. Status: Commercial in the US and Europe; v2.7 software (June 2026) adds automated set-up and AI reports. Next milestone: Roll-out of v2.7 across installed base, target 2026 ## Milestones | Status | Milestone | Date | Slip | | --- | --- | --- | --- | | Done | Company founded | 2020 | | | Done | First FDA 510(k) clearance and first-in-human study | Dec 2022 | | | Done | CE mark for the commercial system | 2023 | | | Done | First US clinical cases | Sep 2023 | | | Done | FDA clearance of the commercial Maestro system | Jun 2024 | | | Done | ScoPilot AI camera control cleared by FDA | 18 Mar 2025 | | | Done | Wi-Fi/5G connectivity and ScoPilot change-control plan cleared | Jul 2025 | | | Done | Software v2.7: automated set-up, third-party AI apps | 9 Jun 2026 | | | Current | Roll-out of v2.7 across installed base | 2026 | | ## Upcoming events - **2026**: Roll-out of v2.7 across installed base ## Most important updates - **9 Jun 2026**: Moon Surgical ships Maestro software 2.7 with automated set-up and the first third-party AI app. Version 2.7 turns Maestro from one AI feature into a platform of several models. ([our story](https://technooptimist.io/stories/moon-surgical-ships-maestro-software-2-7-with-automated-set-up-and-the-ebbc0a25.md) · [original source](https://sofinnovapartners.com/news/moon-surgical-expands-maestro-platform-into-multi-model-physical-ai)) - **18 Mar 2025**: FDA clears Moon Surgical's ScoPilot, an AI feature that makes Maestro's camera follow the surgeon's instrument. The FDA cleared ScoPilot, which lets the laparoscope held by Maestro follow the tip of a chosen instrument on demand. ([our story](https://technooptimist.io/stories/fda-clears-moon-surgical-s-scopilot-an-ai-feature-that-makes-maestro-s-8130f24d.md) · [original source](https://www.prnewswire.com/news-releases/moon-surgical-receives-fda-clearance-for-scopilot-on-maestro-industrys-first-ai-enhanced-intraoperative-capability-powered-by--nvidia-holoscan-302404920.html)) ## Current obstacles - **Regulating learning software**: AI features that improve over time need an FDA-approved change plan; ScoPilot got one in 2025, but each new capability still needs validation. - **Patient data in AI training**: Recording video and motion in the OR raises consent and data-governance questions as the dataset grows. ## Physics limits - **Seeing only through the camera**: Vision models see what one laparoscope shows; smoke, blood and fogging hide instruments, so automated camera control must fall back to the surgeon. - **Hand-held surgery's limits remain**: The surgeon still operates with straight hand instruments, so Maestro adds steadiness and camera control, not the wristed dexterity of a full robot. ## How it works ### Arms: Two arms that lock where you leave them The surgeon positions each arm by hand; it feels weightless while moving and locks rigidly when released, holding a scope or retractor steady. ### Instruments: Uses the surgeon's own tools Maestro holds most standard 5-10 mm laparoscopic instruments and scopes, so hospitals keep their existing kit and technique. ### ScoPilot: Camera follows the instrument tip On demand, a vision model tracks the tip of a chosen instrument and moves the laparoscope to keep it centred, without the surgeon letting go of their tools. ### Data: Recording every case Sensors and arm motion data from each case build a dataset used to train and validate new automation, such as automatic set-up. ## Spec sheet | Spec | Maestro | Provenance | | --- | --- | --- | | Robotic arms | 2 | reported | | Instrument compatibility | Most 5-10 mm instruments and scopes | reported | | Patients treated (Mar 2025) | 1,100+ | reported | | Procedure dataset (Jun 2026) | 3,000+ procedures | reported | | Surgeon learning curve | 3-5 procedures | reported | Provenance: reported = stated by the company; estimated = our estimate; sample = a sample figure. ## Papers and demos - **2023** (paper): [First-in-human study of the Maestro system (Surgical Endoscopy)](https://link.springer.com/article/10.1007/s00464-023-10296-3). Peer-reviewed first clinical use of the co-manipulation arms in laparoscopy. ## About Moon Surgical Franco-American company, founded in 2020 and based in Paris and San Francisco, making Maestro: a bedside robot that holds the camera and retractors in keyhole surgery so the surgeon works with their usual instruments. - Maestro is an assistant, not a replacement robot: two arms hold the camera and instruments while the surgeon operates normally. - ScoPilot (FDA-cleared Mar 2025) makes the camera follow the surgeon's instrument tip, running on NVIDIA Holoscan. - Over 1,100 patients treated by March 2025; a dataset of 3,000+ procedures trains its AI (June 2026). - Founded: 2020 - Headquarters: FR, US - Status: private - Website: https://www.moonsurgical.com - People: Anne Osdoit (CEO) - Partners, customers, investors: NVIDIA (partner); Sofinnova Partners (investor); Lee Health (customer) Company page: https://technooptimist.io/companies/moon-surgical.md ## Related programs Everything in Robotics: https://technooptimist.io/robotics.md --- The Techno Optimist tracks every frontier of technology, program by program: https://technooptimist.io/ (a Markdown version of any page: add .md to its URL; site map for agents: https://technooptimist.io/llms.txt). Data API (JSON, realtime stream): https://technooptimist.io/developers. People read 5 pages free, then Reader $10/month; these Markdown pages are open to agents.